These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15608141)

  • 1. Activators of cation channels: potential in treatment of channelopathies.
    Seebohm G
    Mol Pharmacol; 2005 Mar; 67(3):585-8. PubMed ID: 15608141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
    Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
    Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel potent human ether-a-go-go-related gene (hERG) potassium channel enhancers and their in vitro antiarrhythmic activity.
    Zhou J; Augelli-Szafran CE; Bradley JA; Chen X; Koci BJ; Volberg WA; Sun Z; Cordes JS
    Mol Pharmacol; 2005 Sep; 68(3):876-84. PubMed ID: 15976038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saxitoxin is a gating modifier of HERG K+ channels.
    Wang J; Salata JJ; Bennett PB
    J Gen Physiol; 2003 Jun; 121(6):583-98. PubMed ID: 12771193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single amino acid difference between ether-a-go-go- related gene channel subtypes determines differential sensitivity to a small molecule activator.
    Perry M; Sanguinetti MC
    Mol Pharmacol; 2008 Apr; 73(4):1044-51. PubMed ID: 18162604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QT interval prolongation and cardiac risk assessment for novel drugs.
    Picard S; Lacroix P
    Curr Opin Investig Drugs; 2003 Mar; 4(3):303-8. PubMed ID: 12735231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital and acquired long QT syndrome.
    Camm AJ; Janse MJ; Roden DM; Rosen MR; Cinca J; Cobbe SM
    Eur Heart J; 2000 Aug; 21(15):1232-7. PubMed ID: 10924312
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide.
    Paul AA; Witchel HJ; Hancox JC
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1243-50. PubMed ID: 11162661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ion channels. A new wave for heart rhythms.
    Attali B
    Nature; 1996 Nov; 384(6604):24-5. PubMed ID: 8900269
    [No Abstract]   [Full Text] [Related]  

  • 10. Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator.
    Perry M; Sachse FB; Sanguinetti MC
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13827-32. PubMed ID: 17693551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels.
    Chen J; Seebohm G; Sanguinetti MC
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12461-6. PubMed ID: 12209010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HERG channel (dys)function revealed by dynamic action potential clamp technique.
    Berecki G; Zegers JG; Verkerk AO; Bhuiyan ZA; de Jonge B; Veldkamp MW; Wilders R; van Ginneken AC
    Biophys J; 2005 Jan; 88(1):566-78. PubMed ID: 15475579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death.
    Vincent GM
    Annu Rev Med; 1998; 49():263-74. PubMed ID: 9509262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. I(Kr): the hERG channel.
    Tseng GN
    J Mol Cell Cardiol; 2001 May; 33(5):835-49. PubMed ID: 11343409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of human ether-à-go-go-related K+ (HERG) channel inactivation by Cs+ and K+.
    Zhang S; Kehl SJ; Fedida D
    J Physiol; 2003 May; 548(Pt 3):691-702. PubMed ID: 12626667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and role of hERG channels in cancer cells.
    Arcangeli A
    Novartis Found Symp; 2005; 266():225-32; discussion 232-4. PubMed ID: 16050271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes.
    Suessbrich H; Schönherr R; Heinemann SH; Attali B; Lang F; Busch AE
    Br J Pharmacol; 1997 Mar; 120(5):968-74. PubMed ID: 9138706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inherited long QT syndrome: from ion channel to bedside.
    Vincent GM; Timothy K; Fox J; Zhang L
    Cardiol Rev; 1999; 7(1):44-55. PubMed ID: 10348966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New missense mutation (G626V) in the predicted selectivity filter of the HERG channel associated with familial long QT syndrome.
    Jahr S; Lewalter T; Hesch RD; Lüderitz B; Englisch S
    Hum Mutat; 2000 Jun; 15(6):584. PubMed ID: 10862104
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical, genetic, and biophysical characterization of a homozygous HERG mutation causing severe neonatal long QT syndrome.
    Johnson WH; Yang P; Yang T; Lau YR; Mostella BA; Wolff DJ; Roden DM; Benson DW
    Pediatr Res; 2003 May; 53(5):744-8. PubMed ID: 12621127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.